Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma.

Kai XuHong WuChongchong ZhouYuwen BaoMin YuLingli ZhangXin Li

Published in: International journal of clinical pharmacy (2023)

Adding toripalimab to chemotherapy was not cost-effective in patients with advanced ESCC in China.

Keyphrases